Clinical trial
Longterm Transfer of FRozen Encapsulated Multidonor Stool Filtrate or Encapsulated Multidonor Microbiome for Chronic Active Ulcerative COlitis
NCT03843385 is registered in ClinicalTrials.gov with Andreas Stallmach as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Longterm Transfer of FRozen Encapsulated Multidonor Stool Filtrate or Encapsulated Multidonor Microbiome for Chronic Active Ulcerative COlitis
- Lead sponsor
- Andreas Stallmach
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- January 31, 2023
- Completion date
- April 30, 2027
- Enrollment
- 84 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory bowel diseases, ulcerative colitis